Aurinia Pharmaceuticals AUPH Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's total current assets?
- Aurinia Pharmaceuticals (AUPH) reported total current assets of $480.24M in Q1 2026.
- How has Aurinia Pharmaceuticals's total current assets changed year-over-year?
- Aurinia Pharmaceuticals's total current assets increased by 18.4% year-over-year, from $405.76M to $480.24M.
- What is the long-term trend for Aurinia Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's total current assets has grown at a 3.2% compound annual growth rate (CAGR), from $419.43M to $491.97M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.